Luiz Fernando Lima Reis

Luiz Fernando Lima Reis

Auto-generated profile, based on publicly available information

Luiz Fernando Lima Reis

Hospital Sírio-Libanês, Brazil

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 1997 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
AKAseem Kumar
Aseem Kumar
YYYi‐Li Yang
Yi‐Li Yang
Vincenzo FlatiVincenzo Flati
Vincenzo Flati
SDSandy Der
Sandy Der
SKSuzanne Kadereit
Suzanne Kadereit
BWBryan Raymond George Williams
Bryan Raymond George Williams
The interferon (IFN)‐induced double‐stranded RNA (dsRNA)‐activated Ser/Thr protein kinase (PKR) plays a role in the antiviral and antiproliferative effects of IFN. PKR phosphorylates initiation factor eIF2α, thereby inhibiting protein synthesis, and also activates the transcription factor, nuclear factor‐κB (NF‐κB), by phosphorylating the inhibitor of NF‐κB, IκB. Mice devoid of functional PKR (Pkr°/°) derived by targeted gene disruption exhibit a diminished response to IFN‐γ and poly(rI:rC) (pIC). In embryo fibroblasts derived from Pkr°/° mice, interferon regulatory factor 1 (IRF‐1) or guanylate binding protein (Gbp) promoter–reporter constructs were unresponsive to IFN‐γ or pIC but response could be restored by co‐transfection with PKR. The lack of responsiveness could be attributed to a diminished activation of IRF‐1 and/or NF‐κB in response to IFN‐γ or pIC. Thus, PKR acts as a signal transducer for IFN‐stimulated genes dependent on the transcription factors IRF‐1 and NF‐κB.

1 December 1989 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
TFT Fujita
T Fujita
LRL F Reis
L F Reis
NWN Watanabe
N Watanabe
YKY Kimura
Y Kimura
TTT Taniguchi
T Taniguchi
JVJ Vilcek
J Vilcek
Nuclear protein IRF-1 (interferon regulatory factor 1) was earlier shown to bind to cis-acting regulatory elements present on interferon (IFN)-alpha/beta genes and some IFN-inducible genes. Here we show that in both human FS-4 and murine L929 cells, steady-state levels of IRF-1 mRNA were increased by treatment with tumor necrosis factor (TNF), interleukin 1 (IL-1), poly(I).poly(C), or IFN-beta. IRF-1 mRNA induction was also demonstrated in cells treated with calcium ionophore A23187 or with phorbol 12-myristate 13-acetate, but not with epidermal growth factor, dibutyryl-cAMP, or the adenylate cyclase activator forskolin. To determine whether stimulation of IRF-1 mRNA levels correlates with IFN-beta induction, we compared IRF-1 and IFN-beta mRNA levels in cells exposed to various stimuli. In L929 cells, treatment with poly(I).poly(C) under conditions that failed to induce significant levels of IFN-beta mRNA led to a very low induction of IRF-1 mRNA, but "priming" cells with IFN prior to the addition of poly(I).poly(C) greatly increased both IRF-1 and IFN-beta mRNAs. In FS-4 cells an increase in IFN-beta mRNA (examined by the polymerase chain reaction) was seen after treatment with TNF, IL-1, A23187, or poly(I).poly(C), but not with IFN-beta, epidermal growth factor, dibutyryl-cAMP, or forskolin. Thus, all treatments that increased steady-state levels of IFN-beta mRNA also enhanced IRF-1 mRNA levels. However, treatment with IFN-beta, which caused a marked stimulation in IRF-1 mRNA, failed to produce a detectable increase in IFN-beta mRNA. It appears that IRF-1 may be necessary but not sufficient for IFN-beta induction. The ability of TNF and IL-1 to increase both IRF-1 and IFN-beta mRNAs may be responsible for some similarities in the actions of TNF, IL-1, and the IFNs.

1 October 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
LCLuís Felipe Campesato
Luís Felipe Campesato
RBRomualdo Barroso-Sousa
Romualdo Barroso-Sousa
LJLeandro Jimenez
Leandro Jimenez
BCBruna R. Correa
Bruna R. Correa
JSJorge Sabbaga
Jorge Sabbaga
ACAnamaria Camargo
Anamaria Camargo
Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice

15 October 2005 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
MFMaria Aparecida Folgueira
Maria Aparecida Folgueira
DCDirce Maria Carraro
Dirce Maria Carraro
HBHelena Brentani
Helena Brentani
DPDiogo Ferreira da Costa Patrão
Diogo Ferreira da Costa Patrão
EBEdson Mantovani Barbosa
Edson Mantovani Barbosa
MBMaria Mitzi Brentani
Maria Mitzi Brentani
Purpose: This study was designed to identify genes that could predict response to doxorubicin-based primary chemotherapy in breast cancer patients.

1 February 2002 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
NSNeide M. Silva
Neide M. Silva
CRCibele V. Rodrigues
Cibele V. Rodrigues
MSMarcelo M. Santoro
Marcelo M. Santoro
LRLuiz F. L. Reis
Luiz F. L. Reis
Jacqueline Isaura Alvarez-LeiteJacqueline Isaura Alvarez-Leite
Jacqueline Isaura Alvarez-Leite
RGRicardo T. Gazzinelli
Ricardo T. Gazzinelli
The induction of indoleamine 2,3-dioxygenase (INDO) expression and the tryptophan (Trp)-kynurenine (Kyn) metabolic pathway during in vivo infection withToxoplasma gondiiwas investigated. Decreased levels of Trp and increased formation of Kyn were observed in the lungs, brain, and serum from mice infected withT. gondii. Maximal INDO mRNA expression and enzyme activity were detected in the lungs at 10 to 20 days postinfection. Further, the induction of INDO mRNA expression, Trp degradation and Kyn formation were completely absent in tissues from mice deficient in IFN-γ (IFN-γ−/−) or IFN regulatory factor -1 (IRF-1−/−). These findings indicate the important role of endogenous IFN-γ and IRF-1 in the in vivo induction of the Trp-Kyn metabolic pathway during acute infection withT. gondii. In contrast, expression of INDO mRNA and its activity was preserved in the tissues of TNF-receptor p55- or inducible nitric oxide synthase-deficient mice infected withT. gondii. Together with the results showing the extreme susceptibility of the IFN-γ−/−and the IRF-1−/−mice to infection withT. gondii, our results indicate a possible involvement of INDO and Trp degradation in host resistance to early infection with this parasite.

1 May 2002 in The American Journal of Pathology
Verified
Journal Article
Closed access
DSDanielle G. Souza
Danielle G. Souza
ASAdriana C. Soares
Adriana C. Soares
Vanessa PinhoVanessa Pinho
Vanessa Pinho
HTHumberto Torloni
Humberto Torloni
LRLuiz F.L. Reis
Luiz F.L. Reis
ADAdriana Dias
Adriana Dias